eMHefOBh A.ttMAr 3PVYJI M3H,II,Diffi r A3Phm ~rLm

TYlllAAJI

Ldl9 OHbl ll1'caPblH Il-eAep .Qyraap A/2f

r ,Xysaapb 6aTnax TYxaVi

MOHron YnCblH 3acr~ViH ra3pblH 2016 OHbl 121 p,yr33p TOrTOOnOop 6aTnarp,caH

"MoHron YncblH 3acr~ViH ra3pblH 2016-2020 OHbl yVin a>K~nnaraaHbl xeTen6ep~Vir

X3P311KYYn3x yVin a>K~nnaraaHbl Tenesneree"-H~Vi 3.1.7.5-blr YHp,3cn3H TYWAAX Hb:

1. )K~p3Mcn3nT33c c3pr~Vin3X 3M, 3MH3nr~ViH X3p3rCn~ViH XaHraM>K~ViH

TOrTSOPTOVi 6aVip,nblr XaHraX 30p~nrOOp eMHerosb aViMr~VlH 3M3rT3Vi~yyp"

3anyy~yyp,bIH 3pyyn M3Hp,~Vir p,3M>K~X H3rp,C3H xeTen6ep~ViH XYP33Hp, H3rp,C3H

YHp,3CH~Vi 6aViryynnarblH XYH AMblH CaHraaC H~Vinyyn3rp,c3H >KHp3MCn3nT33C

C3prHVin3X 3MHViH xySaapHVlr xaSCpanTaap 6aTancyraVi .

2. XysaapHnarp,caH 3MHVir 3pr3nTHViH xepeHrHViH 6YPTr3np, as~, HexeH yp>KHxyViH

HaCHbl 30pHnToT /3M33r/ 6ynrHViH 3M3rT3V1~yyp,3p, xypr3x, 3apLlyynanTap, XflHanT

TaSb>K, ynHpan 6yp TaVinarHa>K a>K~nnaXblr 6yx 3pyyn M3Hp,HViH 6aViryynnarblH p,apra

3pxn3~ HapT yyp3r 6onrocyraVi.

3.TywaanblH X3p3r>KHnT3p, XflHanT TaSb>K a>KV1nnaXblr 3pyyn M3Hp,V1ViH ra3pblH

3MH3nrV1ViH TycnaM>K yVinYHnr33HHVi x3nTcHVlH p,apra /)K.OTroH6aViran/, HexeH

yp>KV1xyViH 3pyyn M3Hp, xapHYLlcaH M3pr3>KHnT3H / 5.5aflpMaa / HapT p,aanracyraVi.

I1AprA ¢f/ ~ L\.9H9P>KAprAll

c:\ Desktop\2019 on TUSHAAL

3pyyn M3HA~II1H ra3pblH AaprblH 2019 OHbl 04 capblH 17-Hbl eAP~II1H a/24

TOOT TYWaanblH XaBCpanT

8MHeroBb a~Mar 3M3rT3~4YYA, 3anYY4YYAblH 3pyyJ1 M3HA~~r A3M>K~X xeTeJ16ep~v,H Xyp33HA H~V1J1yyJ13rAC3H >KV1P3MCJ13J1T33C C3prV1v,J13X 3MV1V1H xyBaapb

NQ 3M X3p3rCm'~H H3p

levonorgestrel 0.15mg+ethiny

lestradiol 0.03mg N228

H3r 6yplo1~H

YH3/0 .25$1

5yrA YH3 1$1

levonorgestrel 0.75 Mr N22

H3r 6yplo1~H

yH3 10 .21$1

5yrA YH3 1$1

H~Hnvvn3rAC3H TOO X3M>K33 2,205 0.25 551.25 600 0.21 126.00

1 6aftHAaIla~ C3MT 75 0.25 18.75 20 0.21 4.20

2 5aftH-OSOO C3MT 75 0.25 18.75 20 0.21 4.20

5ymaH C3MT 63 0.25 15.75 20 0.21 4.20

3 rypsaH T3C C3MT 90 0.25 22.50 30 0.21 6.30

4 rypeaH T3C 8csep yel<1~H Ka6l<1HeT 60 0.25 15.00 20 0.21 4.20

5 MaHAaIl-Oeoo C3MT 75 0.25 18.75 20 0.21 4.20

6 MaHIla~ C3MT 90 0.25 22.50 25 0.21 5.25

7 HoeH CA3 102 0.25 25.50 25 0.21 5.25

8 HOMrOH C3MT 75 0.25 18.75 25 0.21 5.25

9 C3SP3~ C3MT 75 0.25 18.75 25 0.21 5.25

10 XaH60rA CA3 150 0.25 37 .50 30 0.21 6.30

11 XaH60rA CA3- 8csep yel<1~H KIll<1Hl<1K 90 0.25 22 .50 20 0.21 4.20

12 XaHxoHrop C3MT 90 0.25 22.50 25 0.21 5.25

13 XYPM3H C3MT 75 0.25 18.75 20 0.21 4.20

14 WOrT-OBoo C3MT 75 0.25 18.75 25 0.21 5.25

15 WOrTI..\31..\l<1~ CA3 120 0.25 30.00 20 0.21 4.20

16 L\OrTI..\31..\l<1i-i CA3 ­8ceep yelo1~H KIll<1Hl<1K 75 0.25 18.75 30 0.21 6.30

17 503T- HexeH YP>KXY~H Ka6l<1HeT 150 0.25 37.50 20 0.21 4.20

18 503T-. 8csep yel<1~H Ka6lo1HeT 60 0.25 15.00 20 0.21 4.20

19 8H8-opwl<1X 83MT 135 0.25 33.75 40 0.21 8.40

20 Wl<1M6l<1Il3r 83MT 135 0.25 33.75 40 0.21 8.40

21 3HXl<1~H XYCIl3H 83MT 135 0.25 33 .75 40 0.21 8.40

22 3H3PXY~ -YxaaH 83MT 135 0.25 33.75 40 0.21 8.40

23 CypramaHA X3P3rJl3C3H 0 0.25 0.00 0 0.21 0.00

24 H~HT xyBaap~ncaH

TOO 2,205 551.25 600 252.00

XYBaapb rapracaH: 3TYX-~~H M3pr3)f(~J1T3H